BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 37163372)

  • 1. Acetyl-CoA carboxylase 1 is a suppressor of the adipocyte thermogenic program.
    Guilherme A; Rowland LA; Wetoska N; Tsagkaraki E; Santos KB; Bedard AH; Henriques F; Kelly M; Munroe S; Pedersen DJ; Ilkayeva OR; Koves TR; Tauer L; Pan M; Han X; Kim JK; Newgard CB; Muoio DM; Czech MP
    Cell Rep; 2023 May; 42(5):112488. PubMed ID: 37163372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adipocyte lipid synthesis coupled to neuronal control of thermogenic programming.
    Guilherme A; Pedersen DJ; Henchey E; Henriques FS; Danai LV; Shen Y; Yenilmez B; Jung D; Kim JK; Lodhi IJ; Semenkovich CF; Czech MP
    Mol Metab; 2017 Aug; 6(8):781-796. PubMed ID: 28752043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic de novo lipogenesis is present in liver-specific ACC1-deficient mice.
    Harada N; Oda Z; Hara Y; Fujinami K; Okawa M; Ohbuchi K; Yonemoto M; Ikeda Y; Ohwaki K; Aragane K; Tamai Y; Kusunoki J
    Mol Cell Biol; 2007 Mar; 27(5):1881-8. PubMed ID: 17210641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paradoxical activation of transcription factor SREBP1c and de novo lipogenesis by hepatocyte-selective ATP-citrate lyase depletion in obese mice.
    Yenilmez B; Kelly M; Zhang GF; Wetoska N; Ilkayeva OR; Min K; Rowland L; DiMarzio C; He W; Raymond N; Lifshitz L; Pan M; Han X; Xie J; Friedline RH; Kim JK; Gao G; Herman MA; Newgard CB; Czech MP
    J Biol Chem; 2022 Oct; 298(10):102401. PubMed ID: 35988648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FGF21 does not require adipocyte AMP-activated protein kinase (AMPK) or the phosphorylation of acetyl-CoA carboxylase (ACC) to mediate improvements in whole-body glucose homeostasis.
    Mottillo EP; Desjardins EM; Fritzen AM; Zou VZ; Crane JD; Yabut JM; Kiens B; Erion DM; Lanba A; Granneman JG; Talukdar S; Steinberg GR
    Mol Metab; 2017 Jun; 6(6):471-481. PubMed ID: 28580278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adipocyte-specific mTORC2 deficiency impairs BAT and iWAT thermogenic capacity without affecting glucose uptake and energy expenditure in cold-acclimated mice.
    Castro É; Vieira TS; Oliveira TE; Ortiz-Silva M; Andrade ML; Tomazelli CA; Peixoto AS; Sobrinho CR; Moreno MF; Gilio GR; Moreira RJ; Guimarães RC; Perandini LA; Chimin P; Reckziegel P; Moretti EH; Steiner AA; Laplante M; Festuccia WT
    Am J Physiol Endocrinol Metab; 2021 Nov; 321(5):E592-E605. PubMed ID: 34541875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of fatty acid synthesis and malonyl-CoA content in mouse brown adipose tissue in response to cold-exposure, starvation or re-feeding.
    Buckley MG; Rath EA
    Biochem J; 1987 Apr; 243(2):437-42. PubMed ID: 2888457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutant mice lacking acetyl-CoA carboxylase 1 are embryonically lethal.
    Abu-Elheiga L; Matzuk MM; Kordari P; Oh W; Shaikenov T; Gu Z; Wakil SJ
    Proc Natl Acad Sci U S A; 2005 Aug; 102(34):12011-6. PubMed ID: 16103361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective Acetyl-CoA Carboxylase 1 Inhibitor Improves Hepatic Steatosis and Hepatic Fibrosis in a Preclinical Nonalcoholic Steatohepatitis Model.
    Tamura YO; Sugama J; Iwasaki S; Sasaki M; Yasuno H; Aoyama K; Watanabe M; Erion DM; Yashiro H
    J Pharmacol Exp Ther; 2021 Nov; 379(3):280-289. PubMed ID: 34535562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of acetyl-CoA carboxylases by soraphen A prevents lipid accumulation and adipocyte differentiation in 3T3-L1 cells.
    Cordonier EL; Jarecke SK; Hollinger FE; Zempleni J
    Eur J Pharmacol; 2016 Jun; 780():202-8. PubMed ID: 27041646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isozyme-nonselective N-substituted bipiperidylcarboxamide acetyl-CoA carboxylase inhibitors reduce tissue malonyl-CoA concentrations, inhibit fatty acid synthesis, and increase fatty acid oxidation in cultured cells and in experimental animals.
    Harwood HJ; Petras SF; Shelly LD; Zaccaro LM; Perry DA; Makowski MR; Hargrove DM; Martin KA; Tracey WR; Chapman JG; Magee WP; Dalvie DK; Soliman VF; Martin WH; Mularski CJ; Eisenbeis SA
    J Biol Chem; 2003 Sep; 278(39):37099-111. PubMed ID: 12842871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving production of malonyl coenzyme A-derived metabolites by abolishing Snf1-dependent regulation of Acc1.
    Shi S; Chen Y; Siewers V; Nielsen J
    mBio; 2014 May; 5(3):e01130-14. PubMed ID: 24803522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver-specific deletion of acetyl-CoA carboxylase 1 reduces hepatic triglyceride accumulation without affecting glucose homeostasis.
    Mao J; DeMayo FJ; Li H; Abu-Elheiga L; Gu Z; Shaikenov TE; Kordari P; Chirala SS; Heird WC; Wakil SJ
    Proc Natl Acad Sci U S A; 2006 May; 103(22):8552-7. PubMed ID: 16717184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuronal modulation of brown adipose activity through perturbation of white adipocyte lipogenesis.
    Guilherme A; Pedersen DJ; Henriques F; Bedard AH; Henchey E; Kelly M; Morgan DA; Rahmouni K; Czech MP
    Mol Metab; 2018 Oct; 16():116-125. PubMed ID: 30005879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ATP-Citrate Lyase Controls a Glucose-to-Acetate Metabolic Switch.
    Zhao S; Torres A; Henry RA; Trefely S; Wallace M; Lee JV; Carrer A; Sengupta A; Campbell SL; Kuo YM; Frey AJ; Meurs N; Viola JM; Blair IA; Weljie AM; Metallo CM; Snyder NW; Andrews AJ; Wellen KE
    Cell Rep; 2016 Oct; 17(4):1037-1052. PubMed ID: 27760311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caveolin-1 regulates hormone resistance through lipid synthesis, creating novel therapeutic opportunities for castration-resistant prostate cancer.
    Karantanos T; Karanika S; Wang J; Yang G; Dobashi M; Park S; Ren C; Li L; Basourakos SP; Hoang A; Efstathiou E; Wang X; Troncoso P; Titus M; Broom B; Kim J; Corn PG; Logothetis CJ; Thompson TC
    Oncotarget; 2016 Jul; 7(29):46321-46334. PubMed ID: 27331874
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Stüve P; Minarrieta L; Erdmann H; Arnold-Schrauf C; Swallow M; Guderian M; Krull F; Hölscher A; Ghorbani P; Behrends J; Abraham WR; Hölscher C; Sparwasser TD; Berod L
    Front Immunol; 2018; 9():495. PubMed ID: 29675017
    [No Abstract]   [Full Text] [Related]  

  • 18. ACC2 is expressed at high levels in human white adipose and has an isoform with a novel N-terminus [corrected].
    Castle JC; Hara Y; Raymond CK; Garrett-Engele P; Ohwaki K; Kan Z; Kusunoki J; Johnson JM
    PLoS One; 2009; 4(2):e4369. PubMed ID: 19190759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of genes regulating malonyl-CoA in human skeletal muscle.
    Pender C; Trentadue AR; Pories WJ; Dohm GL; Houmard JA; Youngren JF
    J Cell Biochem; 2006 Oct; 99(3):860-7. PubMed ID: 16721829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fine-Tuning Lipid Metabolism by Targeting Mitochondria-Associated Acetyl-CoA-Carboxylase 2 in
    Valvo V; Iesato A; Kavanagh TR; Priolo C; Zsengeller Z; Pontecorvi A; Stillman IE; Burke SD; Liu X; Nucera C
    Thyroid; 2021 Sep; 31(9):1335-1358. PubMed ID: 33107403
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.